Identified the first patients with new rare disease caused by defects in cell division. Collaborative study between clinicians and researchers unravels mutations in the BUB1 gene responsible for developmental problems
en-GBde-DEes-ESfr-FR

Identified the first patients with new rare disease caused by defects in cell division. Collaborative study between clinicians and researchers unravels mutations in the BUB1 gene responsible for developmental problems

19.01.2022 Instituto Gulbenkian de Ciência (IGC)

Bitte loggen Sie sich ein oder registrieren Sie sich, um diesen Artikel zu lesen.


Login
Register
19.01.2022 Instituto Gulbenkian de Ciência (IGC)
Regions: Europe, Portugal, Austria, Netherlands
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...

  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by DNN Corp Terms Of Use Privacy Statement